AIDS [clinicaltrials_resource:b1c735ffa03683c4bfbedb3b43d4f647]
Phase III PEG-Intron in HIV-infected Patients (Study P00738) [clinicaltrials:NCT00035360]clinicaltrials:NCT00050089Relaxation Response With Acupuncture for HIV Patients [clinicaltrials:NCT00064740]Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIV [clinicaltrials:NCT00070980]Distant Healing for HIV/AIDS [clinicaltrials:NCT00079534]L-Carnitine to Treat Fatigue in AIDS Patients [clinicaltrials:NCT00079599]Study of Enfuvirtide in HIV-Positive Subjects [clinicaltrials:NCT00086710]clinicaltrials:NCT00095576clinicaltrials:NCT00100698Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS [clinicaltrials:NCT00106795]Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection [clinicaltrials:NCT00113126]DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [clinicaltrials:NCT00116116]Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) [clinicaltrials:NCT00116298]DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [clinicaltrials:NCT00116415]Pediatric Nevirapine Resistance Study [clinicaltrials:NCT00117728]Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) [clinicaltrials:NCT00122538]Buprenorphine and Integrated HIV Care Evaluation [clinicaltrials:NCT00124358]In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults [clinicaltrials:NCT00144352]Comparison of Facility and Home-based ART Delivery Systems in Uganda [clinicaltrials:NCT00144365]Housing and Health Study [clinicaltrials:NCT00153504]The Adult Antiretroviral Treatment and Resistance Study (Tshepo) [clinicaltrials:NCT00197613]clinicaltrials:NCT00202228The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS [clinicaltrials:NCT00202241]To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine [clinicaltrials:NCT00207168]Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission [clinicaltrials:NCT00213083]Once Daily 3TC, Efavirenz and ddI for HIV Infection [clinicaltrials:NCT00214435]The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration [clinicaltrials:NCT00227357]High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease [clinicaltrials:NCT00247143]Motivating HIV+ Women: Risk Reduction and ART Adherence [clinicaltrials:NCT00253045]A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort [clinicaltrials:NCT00268827]Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) [clinicaltrials:NCT00301561]clinicaltrials:NCT00302822clinicaltrials:NCT00317460Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in Mali [clinicaltrials:NCT00339391]HLA-B35 Alleles and AIDS [clinicaltrials:NCT00340223]Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3) [clinicaltrials:NCT00340548]The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis [clinicaltrials:NCT00341172]Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00342602]Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression [clinicaltrials:NCT00344981]clinicaltrials:NCT00346697
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
AIDS [clinicaltrials_resource:b1c735ffa03683c4bfbedb3b43d4f647]
Bio2RDF identifier
b1c735ffa03683c4bfbedb3b43d4f647
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b1c735ffa03683c4bfbedb3b43d4f647
identifier
clinicaltrials_resource:b1c735ffa03683c4bfbedb3b43d4f647
title
AIDS
@en
label
AIDS [clinicaltrials_resource:b1c735ffa03683c4bfbedb3b43d4f647]
@en